List view / Grid view

Dr Milenko Cicmil (Co-founder & Chief Executive Officer - Tasca Therapeutics)

 

article

Mapping lipid pockets to drug the undruggable proteome

Tasca Therapeutics is using chemical proteomics to map lipid-binding pockets…

24 November 2025 | By

Tasca Therapeutics is using chemical proteomics to map lipid-binding pockets on proteins. By targeting auto-palmitoylation, the company aims to turn previously undruggable cancer drivers into viable therapeutic targets.